Plus Therapeutics, Inc. · NASDAQ:PSTV

Clowes Howard exercised options for 922 Plus Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 1, 2026

On Jul 1, 2026, Clowes Howard (Director) exercised options for 922 Plus Therapeutics, Inc. shares, leaving 1,981 shares. Filed Jul 1, 2026 (Form 4).

Options exercised
922 shares
Holding after
1,981 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise9221,981Direct

Source

View original at SEC

Related